OASIS-E Spotlight: Provision of Current Reconciled Medication List to Patient at Discharge

May 22, 2023

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy.

A2123: PROVISION OF CURRENT RECONCILED MEDICATION LIST TO PATIENT AT DISCHARGE

In the last 2 weeks we have looked at the OASIS guidance for providing a reconciled medication list to providers. Now let’s dig into the guidance for proving the list to the patient, family, and/or caregiver at discharge.

Time points:

Discharge from agency

Complete A2123 only if :

M0100, This Assessment is Currently Being Completed for the Following Reason =
9. Discharge from agency
– AND –
M2420 Discharge Disposition =
1. Patient remained in the community (without formal assistive services)
– OR –
4. Unknown, because patient moved to a geographic location not served by this agency
– OR –
UK. Other unknown

At the time of discharge, did your agency provide the patient’s current reconciled medication list to the patient, family, and/or caregiver?

Code 0, No if at discharge to a home setting, your agency did not provide the patient’s current reconciled medication list to the patient, family, and/or caregiver.

Code 1, Yes if at discharge to a subsequent provider, your agency did provide the patient’s current reconciled medication list to the patient, family, and/or caregiver.

Dash IS NOT a valid response for this item.

*NOTE: You can code 1, Yes even if the list is provided only to the patient, only to the family, or only to the caregiver. It is not necessary to provide the list to all of these.

Per the guidance manual:

    • “Communication of medication information to the patient at discharge is critical to ensuring safe and effective discharges. The item, collected at the time of discharge, can improve care coordination, quality of care, aids in medication reconciliation, and may mitigate adverse outcomes related to medications.”
    •  “ It is recommended that a reconciled medication list that is provided to the patient, family, or caregiver use consumer-friendly terminology and plain language to ensure that the information provided to patients and caregivers is clear and understandable.”

We provide clinicians that are part of the KanTime enterprise system with links to the guidance from CMS for each individual OASIS item.

If you would like to learn more about #howbetterhappens

Contact us at sales@kanrad.com to schedule a demo or check out our website at kantime.com

Ready to see How better Happens?

Request a Demo

We Think You May Also Like

BLOG

OASIS-E Spotlight: Route of Current Reconciled Medication List Transmission to Subsequent Provider

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy. A2122: […]

BLOG

OASIS-E Spotlight : Provision of Current Reconciled Medication List to Subsequent Provider at Discharge

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy. A2121: […]

BLOG

Oasis-E Spotlight: Provision of Current Reconciled Medication List to Subsequent Provider at Transfer

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy. A2120: […]